Literature DB >> 22638565

A compound heterozygous missense mutation and a large deletion in the KCTD7 gene presenting as an opsoclonus-myoclonus ataxia-like syndrome.

Lubov Blumkin1, Sara Kivity, Dorit Lev, Sarit Cohen, Ruth Shomrat, Tally Lerman-Sagie, Esther Leshinsky-Silver.   

Abstract

Mutations in the potassium channel-related gene KCTD7 were described so far in a single family with progressive myoclonus epilepsy. We describe a unique phenotype: acute onset of myoclonus and ataxia, associated with abnormal opsoclonus-like eye movements; improvement of clinical symptoms under steroid treatment; and appearance of epileptic activity on EEG 2 years later without overt seizures. After excluding possible genetic causes, whole-genome exome sequencing was performed in order to identify the causative gene. One heterozygous missense mutation (R84W) was detected by exome sequencing and a large heterozygous deletion of exons 3 and 4 by MLPA analysis. The father is heterozygous for the R84W mutation and the mother is heterozygous for the exon 3+4 deletion. The mutation affects a highly conserved segment of the predicted protein, changing a basic amino acid into neutral. The large deletion probably results in a truncated protein. The different phenotype broadens the spectrum of KCTD7-related diseases. Therefore, patients diagnosed as having opsoclonus-myoclonus with an atypical course should be evaluated for KCTD7 mutations.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22638565     DOI: 10.1007/s00415-012-6545-z

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  19 in total

1.  Neonatal seizures associated with a severe neonatal myoclonus like dyskinesia due to a familial KCNQ2 gene mutation.

Authors:  Lubov Blumkin; Arvid Suls; Tine Deconinck; Peter De Jonghe; Ilan Linder; Sara Kivity; Ron Dabby; Esther Leshinsky-Silver; Dorit Lev; Tally Lerman-Sagie
Journal:  Eur J Paediatr Neurol       Date:  2011-12-14       Impact factor: 3.140

2.  A novel splicing mutation in KCNQ2 in a multigenerational family with BFNC followed for 25 years.

Authors:  Gerrit-Jan de Haan; Dalila Pinto; Dietbrandt Carton; Adri Bader; Jorien Witte; Edith Peters; Gerard van Erp; Willem Vandereyken; Eduard Boezeman; Martin C Wapenaar; Paul Boon; Dicky Halley; Bobby P C Koeleman; Dick Lindhout
Journal:  Epilepsia       Date:  2006-05       Impact factor: 5.864

3.  Clinical and neurophysiologic features of progressive myoclonus epilepsy without renal failure caused by SCARB2 mutations.

Authors:  Guido Rubboli; Silvana Franceschetti; Samuel F Berkovic; Laura Canafoglia; Antonio Gambardella; Leanne M Dibbens; Patrizia Riguzzi; Claudio Campieri; Adriana Magaudda; Carlo Alberto Tassinari; Roberto Michelucci
Journal:  Epilepsia       Date:  2011-11-02       Impact factor: 5.864

Review 4.  Opsoclonus myoclonus syndrome in neuroblastoma a report from a workshop on the dancing eyes syndrome at the advances in neuroblastoma meeting in Genoa, Italy, 2004.

Authors:  Katherine K Matthay; Franz Blaes; Barbara Hero; Dominique Plantaz; Pedro De Alarcon; Wendy G Mitchell; Michael Pike; Vito Pistoia
Journal:  Cancer Lett       Date:  2005-10-18       Impact factor: 8.679

5.  Progressive ataxia and myoclonic epilepsy in a patient with a homozygous mutation in the FOLR1 gene.

Authors:  Belén Pérez-Dueñas; Claudio Toma; Aida Ormazábal; Jordi Muchart; Francesc Sanmartí; Georgina Bombau; Mercedes Serrano; Angels García-Cazorla; Bru Cormand; Rafael Artuch
Journal:  J Inherit Metab Dis       Date:  2010-09-21       Impact factor: 4.982

6.  CSF B-cell expansion in opsoclonus-myoclonus syndrome: a biomarker of disease activity.

Authors:  Michael R Pranzatelli; Anna L Travelstead; Elizabeth D Tate; Tyler J Allison; Steven J Verhulst
Journal:  Mov Disord       Date:  2004-07       Impact factor: 10.338

7.  Opsoclonus myoclonus: a non-epileptic movement disorder that may present as status epilepticus.

Authors:  S V Haden; M A McShane; C M Holt
Journal:  Arch Dis Child       Date:  2009-11       Impact factor: 3.791

Review 8.  The neurobiology of the opsoclonus-myoclonus syndrome.

Authors:  M R Pranzatelli
Journal:  Clin Neuropharmacol       Date:  1992-06       Impact factor: 1.592

Review 9.  The autosomal recessively inherited progressive myoclonus epilepsies and their genes.

Authors:  Nivetha Ramachandran; Jean-Marie Girard; Julie Turnbull; Berge A Minassian
Journal:  Epilepsia       Date:  2009-05       Impact factor: 5.864

10.  A homozygous mutation in human PRICKLE1 causes an autosomal-recessive progressive myoclonus epilepsy-ataxia syndrome.

Authors:  Alexander G Bassuk; Robyn H Wallace; Aimee Buhr; Andrew R Buller; Zaid Afawi; Masahito Shimojo; Shingo Miyata; Shan Chen; Pedro Gonzalez-Alegre; Hilary L Griesbach; Shu Wu; Marcus Nashelsky; Eszter K Vladar; Dragana Antic; Polly J Ferguson; Sebahattin Cirak; Thomas Voit; Matthew P Scott; Jeffrey D Axelrod; Christina Gurnett; Azhar S Daoud; Sara Kivity; Miriam Y Neufeld; Aziz Mazarib; Rachel Straussberg; Simri Walid; Amos D Korczyn; Diane C Slusarski; Samuel F Berkovic; Hatem I El-Shanti
Journal:  Am J Hum Genet       Date:  2008-10-30       Impact factor: 11.025

View more
  15 in total

1.  Progressive myoclonic epilepsy-associated gene Kctd7 regulates retinal neurovascular patterning and function.

Authors:  Jonathan Alevy; Courtney A Burger; Nicholas E Albrecht; Danye Jiang; Melanie A Samuel
Journal:  Neurochem Int       Date:  2019-06-06       Impact factor: 3.921

2.  Simultaneous Presentation of Ocular Flutter in Two Sisters.

Authors:  Hugo Morales-Briceño; Mayela Rodríguez-Violante; Amin Cervantes-Arriaga
Journal:  Mov Disord Clin Pract       Date:  2014-07-08

Review 3.  Genetics of the neuronal ceroid lipofuscinoses (Batten disease).

Authors:  Sara E Mole; Susan L Cotman
Journal:  Biochim Biophys Acta       Date:  2015-05-27

Review 4.  Ion Channels in Genetic Epilepsy: From Genes and Mechanisms to Disease-Targeted Therapies.

Authors:  Julia Oyrer; Snezana Maljevic; Ingrid E Scheffer; Samuel F Berkovic; Steven Petrou; Christopher A Reid
Journal:  Pharmacol Rev       Date:  2018-01       Impact factor: 25.468

5.  An unusual clinical severity of 16p11.2 deletion syndrome caused by unmasked recessive mutation of CLN3.

Authors:  Céline Pebrel-Richard; Anne Debost-Legrand; Eléonore Eymard-Pierre; Victoria Greze; Stéphan Kemeny; Mathilde Gay-Bellile; Laetitia Gouas; Andreï Tchirkov; Philippe Vago; Carole Goumy; Christine Francannet
Journal:  Eur J Hum Genet       Date:  2013-07-17       Impact factor: 4.246

6.  KCTD7 deficiency defines a distinct neurodegenerative disorder with a conserved autophagy-lysosome defect.

Authors:  Kyle A Metz; Xinchen Teng; Isabelle Coppens; Heather M Lamb; Bart E Wagner; Jill A Rosenfeld; Xianghui Chen; Yu Zhang; Hee Jong Kim; Michael E Meadow; Tim Sen Wang; Edda D Haberlandt; Glenn W Anderson; Esther Leshinsky-Silver; Weimin Bi; Thomas C Markello; Marsha Pratt; Nawal Makhseed; Adolfo Garnica; Noelle R Danylchuk; Thomas A Burrow; Parul Jayakar; Dianalee McKnight; Satish Agadi; Hatha Gbedawo; Christine Stanley; Michael Alber; Isabelle Prehl; Katrina Peariso; Min Tsui Ong; Santosh R Mordekar; Michael J Parker; Daniel Crooks; Pankaj B Agrawal; Gerard T Berry; Tobias Loddenkemper; Yaping Yang; Gustavo H B Maegawa; Abdel Aouacheria; Janet G Markle; James A Wohlschlegel; Adam L Hartman; J Marie Hardwick
Journal:  Ann Neurol       Date:  2018-11-08       Impact factor: 10.422

Review 7.  Myoclonus-Ataxia Syndromes: A Diagnostic Approach.

Authors:  Malco Rossi; Sterre van der Veen; Marcelo Merello; Marina A J Tijssen; Bart van de Warrenburg
Journal:  Mov Disord Clin Pract       Date:  2020-11-03

Review 8.  KCTD: A new gene family involved in neurodevelopmental and neuropsychiatric disorders.

Authors:  Xinchen Teng; Abdel Aouacheria; Loïc Lionnard; Kyle A Metz; Lucian Soane; Atsushi Kamiya; J Marie Hardwick
Journal:  CNS Neurosci Ther       Date:  2019-07       Impact factor: 5.243

Review 9.  Update on opsoclonus-myoclonus syndrome in adults.

Authors:  Sun-Young Oh; Ji-Soo Kim; Marianne Dieterich
Journal:  J Neurol       Date:  2018-11-27       Impact factor: 4.849

Review 10.  Next-generation sequencing in understanding complex neurological disease.

Authors:  Adam E Handel; Giulio Disanto; Sreeram V Ramagopalan
Journal:  Expert Rev Neurother       Date:  2013-02       Impact factor: 4.618

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.